DK3434671T3 - Sultam forbindelse og fremgangsmåde til anvendelse deraf - Google Patents
Sultam forbindelse og fremgangsmåde til anvendelse deraf Download PDFInfo
- Publication number
- DK3434671T3 DK3434671T3 DK17769434.6T DK17769434T DK3434671T3 DK 3434671 T3 DK3434671 T3 DK 3434671T3 DK 17769434 T DK17769434 T DK 17769434T DK 3434671 T3 DK3434671 T3 DK 3434671T3
- Authority
- DK
- Denmark
- Prior art keywords
- sultam
- connection
- sultam connection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610165138 | 2016-03-22 | ||
| PCT/CN2017/077612 WO2017162157A1 (zh) | 2016-03-22 | 2017-03-22 | 内磺酰胺化合物及其使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3434671T3 true DK3434671T3 (da) | 2021-01-25 |
| DK3434671T5 DK3434671T5 (da) | 2021-03-29 |
Family
ID=59899279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17769434.6T DK3434671T5 (da) | 2016-03-22 | 2017-03-22 | Sultam forbindelse og fremgangsmåde til anvendelse deraf |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11111240B2 (da) |
| EP (1) | EP3434671B1 (da) |
| JP (1) | JP6880166B2 (da) |
| KR (1) | KR102389985B1 (da) |
| CN (2) | CN109071471B (da) |
| AU (1) | AU2017239318B2 (da) |
| BR (1) | BR112018069504B1 (da) |
| CA (1) | CA3018649A1 (da) |
| DK (1) | DK3434671T5 (da) |
| ES (1) | ES2842448T3 (da) |
| PT (1) | PT3434671T (da) |
| RU (1) | RU2741915C9 (da) |
| TW (1) | TWI729094B (da) |
| WO (1) | WO2017162157A1 (da) |
| ZA (1) | ZA201806379B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111065630B (zh) * | 2017-09-22 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 一种内磺酰胺化合物结晶 |
| WO2021028791A1 (en) * | 2019-08-09 | 2021-02-18 | Alembic Pharmaceuticals Limited | An improved process of preparation of ivosidenib |
| WO2023226964A1 (en) * | 2022-05-26 | 2023-11-30 | Danatlas Pharmaceuticals Co., Ltd. | Heterocyclic derivatives, compositions and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100455899B1 (ko) * | 2000-10-20 | 2004-11-08 | 주식회사 티지 바이오텍 | 이소시트릭산 탈수소화 효소 및 그의 유전자 그리고 이효소의 활성 및 그 유전자의 발현을 저해하는 비만,고지혈증, 지방간 등을 포함하는 대사성 질환 치료제의 선별 방법 |
| JP6081354B2 (ja) * | 2010-07-16 | 2017-02-15 | アジオス ファーマシューティカルズ， インコーポレイテッド | 治療活性組成物およびそれらの使用方法 |
| US9474779B2 (en) * | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| MX350432B (es) * | 2012-01-19 | 2017-09-06 | Agios Pharmaceuticals Inc | Compuestos terapeuticamente activos y sus metodos de empleo. |
| WO2015010297A1 (en) * | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
-
2017
- 2017-03-22 WO PCT/CN2017/077612 patent/WO2017162157A1/zh active Application Filing
- 2017-03-22 RU RU2018136487A patent/RU2741915C9/ru active
- 2017-03-22 CA CA3018649A patent/CA3018649A1/en active Pending
- 2017-03-22 ES ES17769434T patent/ES2842448T3/es active Active
- 2017-03-22 CN CN201780018448.8A patent/CN109071471B/zh active Active
- 2017-03-22 DK DK17769434.6T patent/DK3434671T5/da active
- 2017-03-22 US US16/086,721 patent/US11111240B2/en active Active
- 2017-03-22 KR KR1020187030049A patent/KR102389985B1/ko active IP Right Grant
- 2017-03-22 PT PT177694346T patent/PT3434671T/pt unknown
- 2017-03-22 TW TW106109628A patent/TWI729094B/zh active
- 2017-03-22 CN CN202110544835.3A patent/CN113666922A/zh active Pending
- 2017-03-22 EP EP17769434.6A patent/EP3434671B1/en active Active
- 2017-03-22 AU AU2017239318A patent/AU2017239318B2/en active Active
- 2017-03-22 JP JP2019500724A patent/JP6880166B2/ja active Active
- 2017-03-22 BR BR112018069504-1A patent/BR112018069504B1/pt active IP Right Grant
-
2018
- 2018-09-25 ZA ZA2018/06379A patent/ZA201806379B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201736354A (zh) | 2017-10-16 |
| WO2017162157A1 (zh) | 2017-09-28 |
| BR112018069504A2 (pt) | 2019-01-29 |
| DK3434671T5 (da) | 2021-03-29 |
| RU2741915C9 (ru) | 2021-03-31 |
| AU2017239318A1 (en) | 2018-10-18 |
| PT3434671T (pt) | 2020-12-24 |
| KR20180128935A (ko) | 2018-12-04 |
| RU2018136487A (ru) | 2020-04-22 |
| JP6880166B2 (ja) | 2021-06-02 |
| KR102389985B1 (ko) | 2022-04-22 |
| CN113666922A (zh) | 2021-11-19 |
| RU2018136487A3 (da) | 2020-04-24 |
| CN109071471A (zh) | 2018-12-21 |
| EP3434671A1 (en) | 2019-01-30 |
| US11111240B2 (en) | 2021-09-07 |
| ZA201806379B (en) | 2021-03-31 |
| CN109071471B (zh) | 2021-05-07 |
| ES2842448T3 (es) | 2021-07-14 |
| JP2019513819A (ja) | 2019-05-30 |
| US20210047314A1 (en) | 2021-02-18 |
| RU2741915C2 (ru) | 2021-01-29 |
| AU2017239318B2 (en) | 2020-08-20 |
| EP3434671A4 (en) | 2019-08-14 |
| TWI729094B (zh) | 2021-06-01 |
| BR112018069504B1 (pt) | 2023-12-26 |
| EP3434671B1 (en) | 2020-10-21 |
| CA3018649A1 (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3529257T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3436030T3 (da) | Kimæriske receptorer og fremgangsmåder til anvendelse deraf | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3259597T3 (da) | Pvrig-polypeptider og fremgangsmåder til behandling | |
| DK3447137T3 (da) | Flydende enzympræparat og fremgangsmåde til fremstilling deraf | |
| DK3464282T3 (da) | Heteroarylsubstituerede pyridiner og fremgangsmåder til anvendelse | |
| DK3387438T3 (da) | Mikrofluidiske indretninger og kits samt fremgangsmåder til anvendelse heraf | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3209308T3 (da) | Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf | |
| DK3339479T3 (da) | Elektrolyseindretning og elektrolysefremgangsmåde | |
| DK3240895T3 (da) | Sammensætninger og fremgangsmåder til proteinglykosylering | |
| DK3551209T3 (da) | Insulin-fc-fusioner og fremgangsmåder til anvendelse | |
| DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
| DK3453086T3 (da) | Laserindretning og fremgangsmåde til drift deraf | |
| DK3390442T3 (da) | Anti-C5 antistoffer og fremgangsmåde til anvendelse deraf | |
| DK3565828T3 (da) | Sirp1 alpha-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3089971T3 (da) | Forbindelser og fremgangsmåder til anvendelse | |
| DK3551787T3 (da) | Elektropoleringsfremgangsmåde og anlæg hertil | |
| DK3426110T3 (da) | Samling og fremgangsmåde til opskumning af fluid | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3352754T3 (da) | Aldosereduktaseinhibitorer og fremgangsmåder til anvendelse deraf | |
| DK3178980T3 (da) | Stof og fremgangsmåde til stoffremstilling |